Researchers at Moffitt Cancer Center have developed a new chemical approach that could help make targeted cancer medicines ...

Researchers unveil a targeted approach that turns a tumor’s own chemistry against it, opening a new path in cancer research.

The landscape of cancer immunotherapies is evolving rapidly. Although peptides or mRNA vaccines encapsulated in lipid nanoparticles are the most popular platform for personalized cancer vaccines (PVCs ...

Fragment-based drug discovery (FBDD) has emerged as a rigorous and efficient strategy for identifying lead compounds against structurally defined biological ...

Clinical trials for advanced breast cancer have evolved with input from various stakeholders. The heterogeneity in biology and natural history of metastatic breast cancer argues for situation-specific ...

When you hear the word “nanomedicine,” it might call to mind scenarios like those in the 1966 movie “Fantastic Voyage.” The film portrays a medical team shrunken down to ride a microscopic robotic ...